title: [Albendazole for the treatment of hepatic and intra-abdominal hydatidosis].
abstract: Albendazole, in doses of 10mg/kg/day for 28 days with 14 days rest periods between series and series, with a minimum of 3 and a maximum 6 series was administered to 16 patients, 13 women and 3 men, with hepatic and/or of the abdominal cavity hidatid cystes. Clinical, immunological and ultrasonographic criterion were used to evaluate the response, obtaining the following results: complete cure in 6 patients (37.5%), improvement in 7 patients (43.7%) and without change in 3 (18.7%). Drug was tolerated, occurring only one case of reversible total alopecia. There were not abnormalities in liver and renal function tests or in the haematological indices. As conclusion, Albendazole is a good therapeutic alternative in cases of inoperable or multiple hydatid cysts.
authors.affiliation: Departamento de Medicina, Facultad de Medicina, Universidad Nacional Mayor de San Marcos.
authors.forename: H
authors.initials: H
authors.lastname: Vildósola Gonzales
authors.forename: L
authors.initials: L
authors.lastname: Sanchéz
authors.forename: R
authors.initials: R
authors.lastname: Espinoza
mesh_terms: D015766:Albendazole / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004443:Echinococcosis / Q000188:drug therapy*; D004444:Echinococcosis, Hepatic / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D015766:Albendazole
vernacular_title: Albendazol en el tratamiento de la hidatidosis hepática e intrabdominal.